当前位置:首页 - 行情中心 - 沃森生物(300142) - 财务分析 - 资产负债表

沃森生物

(300142)

  

流通市值:208.66亿  总市值:211.59亿
流通股本:15.77亿   总股本:15.99亿

资产负债表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
流动资产:
  货币资金970,096,257.61,352,716,119.411,681,419,365.412,538,243,443.94
  应收票据及应收账款2,287,937,763.462,145,431,189.172,283,925,049.272,366,400,917.07
        应收账款2,287,937,763.462,145,431,189.172,283,925,049.272,366,400,917.07
  预付款项22,842,864.3918,690,274.4227,792,060.4322,247,749.31
  其他应收款合计80,591,622.6979,300,123.4380,308,253.8881,433,833.84
  存货561,735,891.33574,159,308.36545,002,619.18622,759,912.06
  一年内到期的非流动资产317,432,585.67315,747,666.47313,910,166.5312,072,666.53
  其他流动资产88,408,654.260,288,303.39979,925,194.68784,584,612.79
  流动资产合计4,329,045,639.344,546,332,984.655,912,282,709.356,727,743,135.54
非流动资产:
  长期应收款-3,674,511.893,603,523.763,533,289.81
  长期股权投资64,104,472.8514,342,643.3314,571,792.9714,746,539.14
  其他权益工具投资-506,661,256.18474,714,408.93555,000,000
  其他非流动金融资产409,897,860.13428,955,560.13495,700,000417,322,000
  投资性房地产22,220,222.4122,915,703.8223,352,129.723,788,555.66
  固定资产1,692,174,688.181,721,952,437.631,776,835,253.21,830,854,251.09
  在建工程2,300,247,856.522,284,085,833.952,235,887,836.382,158,520,168.57
  使用权资产22,594,843.9526,299,527.3629,716,440.3132,687,340.61
  无形资产816,960,539.17831,432,655.91858,233,546.85889,866,337.97
  开发支出557,933,110.75540,159,139.79506,742,695.87491,476,059.66
  商誉33,657,636.8133,657,636.8133,657,636.8133,657,636.81
  长期待摊费用50,592,961.3846,240,044.7549,146,720.9754,229,957.53
  递延所得税资产106,933,933.14110,810,469.84103,843,701.01102,999,136.99
  其他非流动资产721,920,940.13953,068,835.22733,576,520.58666,077,423.57
  非流动资产合计6,799,239,065.427,524,256,256.617,339,582,207.347,274,758,697.41
  资产总计11,128,284,704.7612,070,589,241.2613,251,864,916.6914,002,501,832.95
流动负债:
  短期借款375,587,009.74163,425,294.93--
  应付票据及应付账款1,295,952,315.461,368,004,694.841,337,852,488.291,691,717,146.23
  其中:应付票据43,197,065.0438,791,871.74-6,773,177.62
        应付账款1,252,755,250.421,329,212,823.11,337,852,488.291,684,943,968.61
  预收款项4,498.425,449.6990.882,477.11
  合同负债15,955,902.5717,704,233.7328,466,329.5129,799,779.72
  应付职工薪酬37,808,519.1678,078,52030,197,753.8729,268,573.49
  应交税费23,382,34523,475,633.5623,531,092.6129,236,838.78
  其他应付款合计62,787,569.88111,139,098.3956,422,145.97407,988,718.03
        应付股利-47,980,456.23-351,137,000
  一年内到期的非流动负债57,297,684.5319,129,383.3118,599,657.9930,527,564.46
  其他流动负债133,142,328.23156,161,076.34183,356,627.92169,557,868.29
  流动负债合计2,001,918,172.991,937,123,384.71,678,427,087.042,388,098,966.11
非流动负债:
  长期借款917,260,221.31189,560,221.31233,997,556.27428,826,162.04
  租赁负债12,818,026.4916,518,506.2119,646,874.9822,166,793.16
  预计负债106,057,127.1497,803,627.2354,401,218.6180,844,156.25
  递延收益260,525,157.27276,769,358.52256,645,425.59262,305,879.38
  递延所得税负债16,235,512.2116,422,146.9565,541,387.8253,961,691.61
  非流动负债合计1,312,896,044.42597,073,860.22630,232,463.27848,104,682.44
  负债合计3,314,814,217.412,534,197,244.922,308,659,550.313,236,203,648.55
所有者权益(或股东权益):
  实收资本(或股本)1,599,348,5411,599,348,5411,599,348,5411,599,348,541
  资本公积2,090,137,555.853,413,546,936.764,548,884,512.544,548,884,512.54
  其他综合收益-384,292,400277,525,000211,225,000
  盈余公积399,395,645.68360,944,023.2981,031,665.6681,031,665.66
  未分配利润3,319,600,256.992,862,858,649.93,176,452,826.213,056,170,567.46
  归属于母公司股东权益合计7,408,481,999.528,620,990,550.959,683,242,545.419,496,660,286.66
  少数股东权益404,988,487.83915,401,445.391,259,962,820.971,269,637,897.74
  股东权益合计7,813,470,487.359,536,391,996.3410,943,205,366.3810,766,298,184.4
  负债和股东权益合计11,128,284,704.7612,070,589,241.2613,251,864,916.6914,002,501,832.95
公告日期2026-04-282026-03-282025-10-292025-08-26
审计意见(境内)标准无保留意见
TOP↑